Chemical formula: C₁₁H₉I₃N₂O₄ Molecular mass: 613.916 g/mol PubChem compound: 3737
Iotalamic acid is intended for use as a diagnostic radiopaque medium. It is used in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V08AA04 | Iotalamic acid | V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| CONRAY Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| CYSTO-CONRAY II Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Iotalamic acid is an active ingredient of these brands:
United States (US)
Canada (CA)
South Africa (ZA)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
